You are here

  • Home
  • Archive
  • Volume 94, Issue 1
  • Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Citation Tools

Article menu

Download PDFPDF

Multiple sclerosis
Short report
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
König M, Lorentzen ÅR, Torgauten HM, et al
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
Journal of Neurology, Neurosurgery & Psychiatry 2023;94:19-22.